Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

10.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective changes in primary care patients' family communication after skin cancer genetic test offer.

PEC innovation·2025
Same author

When Bad News Comes Through the Portal: Strengthening Trust and Guiding Patients When They Receive Bad Results Before Their Clinicians.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2024
Same author

An Initial Examination of ChatGPT Responses to Questions About Decision Making in Advanced Cancer.

Journal of pain and symptom management·2024
Same author

Preventing Physician Suicide-A Role for Consultation-Liaison Psychiatry?

Journal of the Academy of Consultation-Liaison Psychiatry·2023
Same author

Development, Feasibility, and Acceptability of an Oncologist Group Peer Support Program From ASCO's Clinician Well-Being Task Force.

JCO oncology practice·2023
Same author

Psychosocial well-being among patients with malignant pleural mesothelioma.

Palliative & supportive care·2023

Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.3K

Communicating About Precision Oncology.

Daniel C McFarland1, Elizabeth Blackler1, Smita Banerjee1

  • 1, Memorial Sloan Kettering Cancer Center, West Harrison; and , , and , Memorial Sloan Kettering Cancer Center, New York, NY.

JCO Precision Oncology
|September 11, 2020
PubMed
Summary

Precision medicine in oncology presents new communication challenges. This study offers guidance on discussing genomic information and shared decision-making to support patients facing uncertainty.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

1.1K

Related Experiment Videos

Last Updated: Dec 9, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.3K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

1.1K

Area of Science:

  • Oncology
  • Genomic Medicine
  • Medical Communication

Background:

  • Communication in oncology is complex, further challenged by genomic data in precision medicine.
  • Patient psychological responses to genomic treatments and outcomes add layers of complexity.
  • Existing communication challenges include providing hope and obtaining informed consent.

Purpose of the Study:

  • To present common patient reactions to precision medicine scenarios in oncology.
  • To highlight clinical and ethical communication issues, including informed consent, shared decision-making, patient autonomy, and treatment uncertainty.
  • To provide communication strategies using a Shared Decision Making framework.

Main Methods:

  • Analysis of common patient reactions to genomic information in oncology practice.
  • Identification of clinical and ethical communication challenges.
  • Development of communication suggestions based on a Shared Decision Making framework.

Main Results:

  • Identified specific patient reactions to various precision medicine scenarios.
  • Highlighted the critical role of informed consent, shared decision-making, patient autonomy, and managing uncertainty.
  • Provided practical communication guidance for oncologists.

Conclusions:

  • Effective communication is paramount in the era of precision oncology.
  • A Shared Decision Making approach can help patients navigate distress and uncertainty associated with genomic information.
  • Addressing clinical and ethical considerations is essential for optimal patient care.